Wells Fargo lifts Colgate‑Palmolive price target to $95 and keeps Equal‑Weight rating

Wells Fargo raised its price target for Colgate‑Palmolive to $95 from $90 while maintaining an Equal‑Weight rating. The change follows the company’s third‑quarter 2026 results, which posted adjusted earnings of $0.97 per share on revenue of $5.37 billion. The analyst highlighted the firm’s strong margin performance and resilience amid inflation pressures.

The higher target suggests potential upside for investors, as the stock now trades near the new $95 target. Wells Fargo’s rating and target may influence market sentiment toward CL.

  • 1Wells Fargo raised its price target for Colgate‑Palmolive to $95.00 from $90.00.
  • 2Wells Fargo kept an Equal‑Weight rating on the stock.
  • 3Colgate‑Palmolive reported adjusted third‑quarter 2026 earnings of $0.97 per share.
  • 4Colgate‑Palmolive reported third‑quarter 2026 revenue of $5.37 billion.
  • 5The stock’s P/E ratio was 37.77 at the time of the report.
  • 6Wells Fargo’s price‑target increase aligns with the stock’s close of $95.29 on the day.

Sources